 | • レポートコード：MRC2-11QY12984 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は静脈性下肢潰瘍治療のグローバル市場について調査・分析したレポートです。種類別（CureXcell、CVBT-141B、Granexin、HP-802247、その他）市場規模、用途別（病院、診療所、家庭用）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別静脈性下肢潰瘍治療の競争状況、市場シェア ・世界の静脈性下肢潰瘍治療市場：種類別市場規模 2015年-2020年（CureXcell、CVBT-141B、Granexin、HP-802247、その他） ・世界の静脈性下肢潰瘍治療市場：種類別市場規模予測 2021年-2026年（CureXcell、CVBT-141B、Granexin、HP-802247、その他） ・世界の静脈性下肢潰瘍治療市場：用途別市場規模 2015年-2020年（病院、診療所、家庭用） ・世界の静脈性下肢潰瘍治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、家庭用） ・北米の静脈性下肢潰瘍治療市場分析：米国、カナダ ・ヨーロッパの静脈性下肢潰瘍治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの静脈性下肢潰瘍治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の静脈性下肢潰瘍治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの静脈性下肢潰瘍治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：CardioVascular BioTherapeutics Inc、CytoTools AG、Daval International Ltd、Factor Therapeutics Ltd、FirstString Research Inc、GangaGen Inc、Hypo-Stream Ltd、Leap Therapeutics Inc、MediWound Ltd、NovaLead Pharma Pvt Ltd、Promore Pharma、RegeneRx Biopharmaceuticals Inc、RMB-Research GmbH、Stratatech Corp ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Venous Leg Ulcers Treatment Market
The global Venous Leg Ulcers Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Venous Leg Ulcers Treatment Scope and Market Size
Venous Leg Ulcers Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Venous Leg Ulcers Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Venous Leg Ulcers Treatment market is segmented into
CureXcell
CVBT-141B
Granexin
HP-802247
Others
Segment by Application, the Venous Leg Ulcers Treatment market is segmented into
Hospital
Clinic
Home Use
Regional and Country-level Analysis
The Venous Leg Ulcers Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Venous Leg Ulcers Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Venous Leg Ulcers Treatment Market Share Analysis
Venous Leg Ulcers Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Venous Leg Ulcers Treatment business, the date to enter into the Venous Leg Ulcers Treatment market, Venous Leg Ulcers Treatment product introduction, recent developments, etc.
The major vendors covered:
CardioVascular BioTherapeutics Inc
CytoTools AG
Daval International Ltd
Factor Therapeutics Ltd
FirstString Research Inc
GangaGen Inc
Hypo-Stream Ltd
Leap Therapeutics Inc
MediWound Ltd
NovaLead Pharma Pvt Ltd
Promore Pharma
RegeneRx Biopharmaceuticals Inc
RMB-Research GmbH
Stratatech Corp
1 Study Coverage
1.1 Venous Leg Ulcers Treatment Product Introduction
1.2 Market Segments
1.3 Key Venous Leg Ulcers Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Venous Leg Ulcers Treatment Market Size Growth Rate by Type
1.4.2 CureXcell
1.4.3 CVBT-141B
1.4.4 Granexin
1.4.5 HP-802247
1.4.6 Others
1.5 Market by Application
1.5.1 Global Venous Leg Ulcers Treatment Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Home Use
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Venous Leg Ulcers Treatment Market Size, Estimates and Forecasts
2.1.1 Global Venous Leg Ulcers Treatment Revenue 2015-2026
2.1.2 Global Venous Leg Ulcers Treatment Sales 2015-2026
2.2 Global Venous Leg Ulcers Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Venous Leg Ulcers Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Venous Leg Ulcers Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Venous Leg Ulcers Treatment Competitor Landscape by Players
3.1 Venous Leg Ulcers Treatment Sales by Manufacturers
3.1.1 Venous Leg Ulcers Treatment Sales by Manufacturers (2015-2020)
3.1.2 Venous Leg Ulcers Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Venous Leg Ulcers Treatment Revenue by Manufacturers
3.2.1 Venous Leg Ulcers Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Venous Leg Ulcers Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Venous Leg Ulcers Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Venous Leg Ulcers Treatment Revenue in 2019
3.2.5 Global Venous Leg Ulcers Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Venous Leg Ulcers Treatment Price by Manufacturers
3.4 Venous Leg Ulcers Treatment Manufacturing Base Distribution, Product Types
3.4.1 Venous Leg Ulcers Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Venous Leg Ulcers Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Venous Leg Ulcers Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Venous Leg Ulcers Treatment Market Size by Type (2015-2020)
4.1.1 Global Venous Leg Ulcers Treatment Sales by Type (2015-2020)
4.1.2 Global Venous Leg Ulcers Treatment Revenue by Type (2015-2020)
4.1.3 Venous Leg Ulcers Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Venous Leg Ulcers Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Venous Leg Ulcers Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Venous Leg Ulcers Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Venous Leg Ulcers Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Venous Leg Ulcers Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Venous Leg Ulcers Treatment Market Size by Application (2015-2020)
5.1.1 Global Venous Leg Ulcers Treatment Sales by Application (2015-2020)
5.1.2 Global Venous Leg Ulcers Treatment Revenue by Application (2015-2020)
5.1.3 Venous Leg Ulcers Treatment Price by Application (2015-2020)
5.2 Venous Leg Ulcers Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Venous Leg Ulcers Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Venous Leg Ulcers Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Venous Leg Ulcers Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Venous Leg Ulcers Treatment by Country
6.1.1 North America Venous Leg Ulcers Treatment Sales by Country
6.1.2 North America Venous Leg Ulcers Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Venous Leg Ulcers Treatment Market Facts & Figures by Type
6.3 North America Venous Leg Ulcers Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Venous Leg Ulcers Treatment by Country
7.1.1 Europe Venous Leg Ulcers Treatment Sales by Country
7.1.2 Europe Venous Leg Ulcers Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Venous Leg Ulcers Treatment Market Facts & Figures by Type
7.3 Europe Venous Leg Ulcers Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Venous Leg Ulcers Treatment by Region
8.1.1 Asia Pacific Venous Leg Ulcers Treatment Sales by Region
8.1.2 Asia Pacific Venous Leg Ulcers Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Venous Leg Ulcers Treatment Market Facts & Figures by Type
8.3 Asia Pacific Venous Leg Ulcers Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Venous Leg Ulcers Treatment by Country
9.1.1 Latin America Venous Leg Ulcers Treatment Sales by Country
9.1.2 Latin America Venous Leg Ulcers Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Venous Leg Ulcers Treatment Market Facts & Figures by Type
9.3 Central & South America Venous Leg Ulcers Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Venous Leg Ulcers Treatment by Country
10.1.1 Middle East and Africa Venous Leg Ulcers Treatment Sales by Country
10.1.2 Middle East and Africa Venous Leg Ulcers Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Venous Leg Ulcers Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Venous Leg Ulcers Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 CardioVascular BioTherapeutics Inc
11.1.1 CardioVascular BioTherapeutics Inc Corporation Information
11.1.2 CardioVascular BioTherapeutics Inc Description and Business Overview
11.1.3 CardioVascular BioTherapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Products Offered
11.1.5 CardioVascular BioTherapeutics Inc Related Developments
11.2 CytoTools AG
11.2.1 CytoTools AG Corporation Information
11.2.2 CytoTools AG Description and Business Overview
11.2.3 CytoTools AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CytoTools AG Venous Leg Ulcers Treatment Products Offered
11.2.5 CytoTools AG Related Developments
11.3 Daval International Ltd
11.3.1 Daval International Ltd Corporation Information
11.3.2 Daval International Ltd Description and Business Overview
11.3.3 Daval International Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Daval International Ltd Venous Leg Ulcers Treatment Products Offered
11.3.5 Daval International Ltd Related Developments
11.4 Factor Therapeutics Ltd
11.4.1 Factor Therapeutics Ltd Corporation Information
11.4.2 Factor Therapeutics Ltd Description and Business Overview
11.4.3 Factor Therapeutics Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Factor Therapeutics Ltd Venous Leg Ulcers Treatment Products Offered
11.4.5 Factor Therapeutics Ltd Related Developments
11.5 FirstString Research Inc
11.5.1 FirstString Research Inc Corporation Information
11.5.2 FirstString Research Inc Description and Business Overview
11.5.3 FirstString Research Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 FirstString Research Inc Venous Leg Ulcers Treatment Products Offered
11.5.5 FirstString Research Inc Related Developments
11.6 GangaGen Inc
11.6.1 GangaGen Inc Corporation Information
11.6.2 GangaGen Inc Description and Business Overview
11.6.3 GangaGen Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GangaGen Inc Venous Leg Ulcers Treatment Products Offered
11.6.5 GangaGen Inc Related Developments
11.7 Hypo-Stream Ltd
11.7.1 Hypo-Stream Ltd Corporation Information
11.7.2 Hypo-Stream Ltd Description and Business Overview
11.7.3 Hypo-Stream Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hypo-Stream Ltd Venous Leg Ulcers Treatment Products Offered
11.7.5 Hypo-Stream Ltd Related Developments
11.8 Leap Therapeutics Inc
11.8.1 Leap Therapeutics Inc Corporation Information
11.8.2 Leap Therapeutics Inc Description and Business Overview
11.8.3 Leap Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Leap Therapeutics Inc Venous Leg Ulcers Treatment Products Offered
11.8.5 Leap Therapeutics Inc Related Developments
11.9 MediWound Ltd
11.9.1 MediWound Ltd Corporation Information
11.9.2 MediWound Ltd Description and Business Overview
11.9.3 MediWound Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 MediWound Ltd Venous Leg Ulcers Treatment Products Offered
11.9.5 MediWound Ltd Related Developments
11.10 NovaLead Pharma Pvt Ltd
11.10.1 NovaLead Pharma Pvt Ltd Corporation Information
11.10.2 NovaLead Pharma Pvt Ltd Description and Business Overview
11.10.3 NovaLead Pharma Pvt Ltd Sales, Revenue and Gross Margin (2015-2020)
11.10.4 NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Products Offered
11.10.5 NovaLead Pharma Pvt Ltd Related Developments
11.1 CardioVascular BioTherapeutics Inc
11.1.1 CardioVascular BioTherapeutics Inc Corporation Information
11.1.2 CardioVascular BioTherapeutics Inc Description and Business Overview
11.1.3 CardioVascular BioTherapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Products Offered
11.1.5 CardioVascular BioTherapeutics Inc Related Developments
11.12 RegeneRx Biopharmaceuticals Inc
11.12.1 RegeneRx Biopharmaceuticals Inc Corporation Information
11.12.2 RegeneRx Biopharmaceuticals Inc Description and Business Overview
11.12.3 RegeneRx Biopharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.12.4 RegeneRx Biopharmaceuticals Inc Products Offered
11.12.5 RegeneRx Biopharmaceuticals Inc Related Developments
11.13 RMB-Research GmbH
11.13.1 RMB-Research GmbH Corporation Information
11.13.2 RMB-Research GmbH Description and Business Overview
11.13.3 RMB-Research GmbH Sales, Revenue and Gross Margin (2015-2020)
11.13.4 RMB-Research GmbH Products Offered
11.13.5 RMB-Research GmbH Related Developments
11.14 Stratatech Corp
11.14.1 Stratatech Corp Corporation Information
11.14.2 Stratatech Corp Description and Business Overview
11.14.3 Stratatech Corp Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Stratatech Corp Products Offered
11.14.5 Stratatech Corp Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Venous Leg Ulcers Treatment Market Estimates and Projections by Region
12.1.1 Global Venous Leg Ulcers Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Venous Leg Ulcers Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Venous Leg Ulcers Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Venous Leg Ulcers Treatment Sales Forecast (2021-2026)
12.2.2 North America: Venous Leg Ulcers Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Venous Leg Ulcers Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Venous Leg Ulcers Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Venous Leg Ulcers Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Venous Leg Ulcers Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Venous Leg Ulcers Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Venous Leg Ulcers Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Venous Leg Ulcers Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Venous Leg Ulcers Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Venous Leg Ulcers Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Venous Leg Ulcers Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Venous Leg Ulcers Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Venous Leg Ulcers Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Venous Leg Ulcers Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Venous Leg Ulcers Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Venous Leg Ulcers Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Venous Leg Ulcers Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Venous Leg Ulcers Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Venous Leg Ulcers Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Venous Leg Ulcers Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Venous Leg Ulcers Treatment Market Segments
Table 2. Ranking of Global Top Venous Leg Ulcers Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Venous Leg Ulcers Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of CureXcell
Table 5. Major Manufacturers of CVBT-141B
Table 6. Major Manufacturers of Granexin
Table 7. Major Manufacturers of HP-802247
Table 8. Major Manufacturers of Others
Table 9. Global Venous Leg Ulcers Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Venous Leg Ulcers Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Venous Leg Ulcers Treatment Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Venous Leg Ulcers Treatment Sales Market Share by Regions (2015-2020)
Table 13. Global Venous Leg Ulcers Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Venous Leg Ulcers Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Venous Leg Ulcers Treatment Sales Share by Manufacturers (2015-2020)
Table 16. Global Venous Leg Ulcers Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Venous Leg Ulcers Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Venous Leg Ulcers Treatment as of 2019)
Table 18. Venous Leg Ulcers Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Venous Leg Ulcers Treatment Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Venous Leg Ulcers Treatment Price (2015-2020) (USD/Pcs)
Table 21. Venous Leg Ulcers Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Venous Leg Ulcers Treatment Product Type
Table 23. Date of International Manufacturers Enter into Venous Leg Ulcers Treatment Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Venous Leg Ulcers Treatment Sales by Type (2015-2020) (K Pcs)
Table 26. Global Venous Leg Ulcers Treatment Sales Share by Type (2015-2020)
Table 27. Global Venous Leg Ulcers Treatment Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Venous Leg Ulcers Treatment Revenue Share by Type (2015-2020)
Table 29. Venous Leg Ulcers Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Venous Leg Ulcers Treatment Sales by Application (2015-2020) (K Pcs)
Table 31. Global Venous Leg Ulcers Treatment Sales Share by Application (2015-2020)
Table 32. North America Venous Leg Ulcers Treatment Sales by Country (2015-2020) (K Pcs)
Table 33. North America Venous Leg Ulcers Treatment Sales Market Share by Country (2015-2020)
Table 34. North America Venous Leg Ulcers Treatment Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Venous Leg Ulcers Treatment Revenue Market Share by Country (2015-2020)
Table 36. North America Venous Leg Ulcers Treatment Sales by Type (2015-2020) (K Pcs)
Table 37. North America Venous Leg Ulcers Treatment Sales Market Share by Type (2015-2020)
Table 38. North America Venous Leg Ulcers Treatment Sales by Application (2015-2020) (K Pcs)
Table 39. North America Venous Leg Ulcers Treatment Sales Market Share by Application (2015-2020)
Table 40. Europe Venous Leg Ulcers Treatment Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Venous Leg Ulcers Treatment Sales Market Share by Country (2015-2020)
Table 42. Europe Venous Leg Ulcers Treatment Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Venous Leg Ulcers Treatment Revenue Market Share by Country (2015-2020)
Table 44. Europe Venous Leg Ulcers Treatment Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Venous Leg Ulcers Treatment Sales Market Share by Type (2015-2020)
Table 46. Europe Venous Leg Ulcers Treatment Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Venous Leg Ulcers Treatment Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Venous Leg Ulcers Treatment Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Venous Leg Ulcers Treatment Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Venous Leg Ulcers Treatment Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Venous Leg Ulcers Treatment Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Venous Leg Ulcers Treatment Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Venous Leg Ulcers Treatment Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Venous Leg Ulcers Treatment Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Venous Leg Ulcers Treatment Sales Market Share by Application (2015-2020)
Table 56. Latin America Venous Leg Ulcers Treatment Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Venous Leg Ulcers Treatment Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Venous Leg Ulcers Treatment Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Venous Leg Ulcers Treatment Revenue Market Share by Country (2015-2020)
Table 60. Latin America Venous Leg Ulcers Treatment Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Venous Leg Ulcers Treatment Sales Market Share by Type (2015-2020)
Table 62. Latin America Venous Leg Ulcers Treatment Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Venous Leg Ulcers Treatment Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Venous Leg Ulcers Treatment Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Venous Leg Ulcers Treatment Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Venous Leg Ulcers Treatment Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Venous Leg Ulcers Treatment Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Venous Leg Ulcers Treatment Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Venous Leg Ulcers Treatment Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Venous Leg Ulcers Treatment Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Venous Leg Ulcers Treatment Sales Market Share by Application (2015-2020)
Table 72. CardioVascular BioTherapeutics Inc Corporation Information
Table 73. CardioVascular BioTherapeutics Inc Description and Major Businesses
Table 74. CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. CardioVascular BioTherapeutics Inc Product
Table 76. CardioVascular BioTherapeutics Inc Recent Development
Table 77. CytoTools AG Corporation Information
Table 78. CytoTools AG Description and Major Businesses
Table 79. CytoTools AG Venous Leg Ulcers Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. CytoTools AG Product
Table 81. CytoTools AG Recent Development
Table 82. Daval International Ltd Corporation Information
Table 83. Daval International Ltd Description and Major Businesses
Table 84. Daval International Ltd Venous Leg Ulcers Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Daval International Ltd Product
Table 86. Daval International Ltd Recent Development
Table 87. Factor Therapeutics Ltd Corporation Information
Table 88. Factor Therapeutics Ltd Description and Major Businesses
Table 89. Factor Therapeutics Ltd Venous Leg Ulcers Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Factor Therapeutics Ltd Product
Table 91. Factor Therapeutics Ltd Recent Development
Table 92. FirstString Research Inc Corporation Information
Table 93. FirstString Research Inc Description and Major Businesses
Table 94. FirstString Research Inc Venous Leg Ulcers Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. FirstString Research Inc Product
Table 96. FirstString Research Inc Recent Development
Table 97. GangaGen Inc Corporation Information
Table 98. GangaGen Inc Description and Major Businesses
Table 99. GangaGen Inc Venous Leg Ulcers Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. GangaGen Inc Product
Table 101. GangaGen Inc Recent Development
Table 102. Hypo-Stream Ltd Corporation Information
Table 103. Hypo-Stream Ltd Description and Major Businesses
Table 104. Hypo-Stream Ltd Venous Leg Ulcers Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Hypo-Stream Ltd Product
Table 106. Hypo-Stream Ltd Recent Development
Table 107. Leap Therapeutics Inc Corporation Information
Table 108. Leap Therapeutics Inc Description and Major Businesses
Table 109. Leap Therapeutics Inc Venous Leg Ulcers Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Leap Therapeutics Inc Product
Table 111. Leap Therapeutics Inc Recent Development
Table 112. MediWound Ltd Corporation Information
Table 113. MediWound Ltd Description and Major Businesses
Table 114. MediWound Ltd Venous Leg Ulcers Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. MediWound Ltd Product
Table 116. MediWound Ltd Recent Development
Table 117. NovaLead Pharma Pvt Ltd Corporation Information
Table 118. NovaLead Pharma Pvt Ltd Description and Major Businesses
Table 119. NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. NovaLead Pharma Pvt Ltd Product
Table 121. NovaLead Pharma Pvt Ltd Recent Development
Table 122. Promore Pharma Corporation Information
Table 123. Promore Pharma Description and Major Businesses
Table 124. Promore Pharma Venous Leg Ulcers Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Promore Pharma Product
Table 126. Promore Pharma Recent Development
Table 127. RegeneRx Biopharmaceuticals Inc Corporation Information
Table 128. RegeneRx Biopharmaceuticals Inc Description and Major Businesses
Table 129. RegeneRx Biopharmaceuticals Inc Venous Leg Ulcers Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. RegeneRx Biopharmaceuticals Inc Product
Table 131. RegeneRx Biopharmaceuticals Inc Recent Development
Table 132. RMB-Research GmbH Corporation Information
Table 133. RMB-Research GmbH Description and Major Businesses
Table 134. RMB-Research GmbH Venous Leg Ulcers Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. RMB-Research GmbH Product
Table 136. RMB-Research GmbH Recent Development
Table 137. Stratatech Corp Corporation Information
Table 138. Stratatech Corp Description and Major Businesses
Table 139. Stratatech Corp Venous Leg Ulcers Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. Stratatech Corp Product
Table 141. Stratatech Corp Recent Development
Table 142. Global Venous Leg Ulcers Treatment Sales Forecast by Regions (2021-2026) (K Pcs)
Table 143. Global Venous Leg Ulcers Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 144. Global Venous Leg Ulcers Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 145. Global Venous Leg Ulcers Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 146. North America: Venous Leg Ulcers Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 147. North America: Venous Leg Ulcers Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Europe: Venous Leg Ulcers Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 149. Europe: Venous Leg Ulcers Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Asia Pacific: Venous Leg Ulcers Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 151. Asia Pacific: Venous Leg Ulcers Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 152. Latin America: Venous Leg Ulcers Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 153. Latin America: Venous Leg Ulcers Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Middle East and Africa: Venous Leg Ulcers Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 155. Middle East and Africa: Venous Leg Ulcers Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 157. Key Challenges
Table 158. Market Risks
Table 159. Main Points Interviewed from Key Venous Leg Ulcers Treatment Players
Table 160. Venous Leg Ulcers Treatment Customers List
Table 161. Venous Leg Ulcers Treatment Distributors List
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Venous Leg Ulcers Treatment Product Picture
Figure 2. Global Venous Leg Ulcers Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. CureXcell Product Picture
Figure 4. CVBT-141B Product Picture
Figure 5. Granexin Product Picture
Figure 6. HP-802247 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Venous Leg Ulcers Treatment Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Home Use
Figure 12. Venous Leg Ulcers Treatment Report Years Considered
Figure 13. Global Venous Leg Ulcers Treatment Market Size 2015-2026 (US$ Million)
Figure 14. Global Venous Leg Ulcers Treatment Sales 2015-2026 (K Pcs)
Figure 15. Global Venous Leg Ulcers Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Venous Leg Ulcers Treatment Sales Market Share by Region (2015-2020)
Figure 17. Global Venous Leg Ulcers Treatment Sales Market Share by Region in 2019
Figure 18. Global Venous Leg Ulcers Treatment Revenue Market Share by Region (2015-2020)
Figure 19. Global Venous Leg Ulcers Treatment Revenue Market Share by Region in 2019
Figure 20. Global Venous Leg Ulcers Treatment Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Venous Leg Ulcers Treatment Revenue in 2019
Figure 22. Venous Leg Ulcers Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Venous Leg Ulcers Treatment Sales Market Share by Type (2015-2020)
Figure 24. Global Venous Leg Ulcers Treatment Sales Market Share by Type in 2019
Figure 25. Global Venous Leg Ulcers Treatment Revenue Market Share by Type (2015-2020)
Figure 26. Global Venous Leg Ulcers Treatment Revenue Market Share by Type in 2019
Figure 27. Global Venous Leg Ulcers Treatment Market Share by Price Range (2015-2020)
Figure 28. Global Venous Leg Ulcers Treatment Sales Market Share by Application (2015-2020)
Figure 29. Global Venous Leg Ulcers Treatment Sales Market Share by Application in 2019
Figure 30. Global Venous Leg Ulcers Treatment Revenue Market Share by Application (2015-2020)
Figure 31. Global Venous Leg Ulcers Treatment Revenue Market Share by Application in 2019
Figure 32. North America Venous Leg Ulcers Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Venous Leg Ulcers Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Venous Leg Ulcers Treatment Sales Market Share by Country in 2019
Figure 35. North America Venous Leg Ulcers Treatment Revenue Market Share by Country in 2019
Figure 36. U.S. Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Venous Leg Ulcers Treatment Market Share by Type in 2019
Figure 41. North America Venous Leg Ulcers Treatment Market Share by Application in 2019
Figure 42. Europe Venous Leg Ulcers Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Venous Leg Ulcers Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Venous Leg Ulcers Treatment Sales Market Share by Country in 2019
Figure 45. Europe Venous Leg Ulcers Treatment Revenue Market Share by Country in 2019
Figure 46. Germany Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Venous Leg Ulcers Treatment Market Share by Type in 2019
Figure 57. Europe Venous Leg Ulcers Treatment Market Share by Application in 2019
Figure 58. Asia Pacific Venous Leg Ulcers Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Venous Leg Ulcers Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Venous Leg Ulcers Treatment Sales Market Share by Region in 2019
Figure 61. Asia Pacific Venous Leg Ulcers Treatment Revenue Market Share by Region in 2019
Figure 62. China Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Venous Leg Ulcers Treatment Market Share by Type in 2019
Figure 85. Asia Pacific Venous Leg Ulcers Treatment Market Share by Application in 2019
Figure 86. Latin America Venous Leg Ulcers Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Venous Leg Ulcers Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Venous Leg Ulcers Treatment Sales Market Share by Country in 2019
Figure 89. Latin America Venous Leg Ulcers Treatment Revenue Market Share by Country in 2019
Figure 90. Mexico Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Venous Leg Ulcers Treatment Market Share by Type in 2019
Figure 97. Latin America Venous Leg Ulcers Treatment Market Share by Application in 2019
Figure 98. Middle East and Africa Venous Leg Ulcers Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Venous Leg Ulcers Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Venous Leg Ulcers Treatment Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Venous Leg Ulcers Treatment Revenue Market Share by Country in 2019
Figure 102. Turkey Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Venous Leg Ulcers Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Venous Leg Ulcers Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Venous Leg Ulcers Treatment Market Share by Type in 2019
Figure 109. Middle East and Africa Venous Leg Ulcers Treatment Market Share by Application in 2019
Figure 110. North America Venous Leg Ulcers Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Venous Leg Ulcers Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Venous Leg Ulcers Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Venous Leg Ulcers Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Venous Leg Ulcers Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Venous Leg Ulcers Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Venous Leg Ulcers Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Venous Leg Ulcers Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Venous Leg Ulcers Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Venous Leg Ulcers Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
褥瘡治療の世界市場（～2026年） Pressure ulcers are injuries caused to skin and tissue due to prolonged pressure on skin. Pressure ulcer is not lethal; however, extreme stages of pressure ulcer can cause infection. The home health care segment held the smallest market share in 2017. However, the segment is anticipated to expand at…- 消化性潰瘍治療の世界市場（～2026年） Market Analysis and Insights: Global Peptic Ulcers Treatment Market The global Peptic Ulcers Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Peptic Ulcers Treatment Scope and Market Size Peptic Ulcers Treatme…
- 静脈-静脈ECMOシステムの世界市場（～2026年） Market Analysis and Insights: Global Veno-Venous ECMO System Market The global Veno-Venous ECMO System market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veno-Venous ECMO System Scope and Market Size Veno-Venous ECMO Syst…
- 糖尿病性足潰瘍・褥瘡の世界市場（～2026年） Diabetic foot ulcers, are most common chronic wounds in patients suffering from diabetes, and lack of proper treatment of the foot ulcers often lead to progression of the wound resulting in lower extremity / foot amputation. Pressure ulcers are often a cause of lack of movement of the patients, long…
- 静脈血栓塞栓症（VTE）治療薬の世界市場（～2026年） Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in the affected individual (Heit, 2015). In VTE, a DVT is a clot tha…